Funding Rounds
Exagen

Exagen Unknown (2022, $42M)

Exagen

Platform dedicated to helping patients with autoimmune rheumatic diseases through scientific discovery.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Unknown

Raised Amount: $42.03M

Raised Date: 2022-01-01

Investors